journal article·2008-11-11

Structural Equivalence of Br and I Halogen Bonds: A Route to Isostructural Materials with Controllable Properties

Dominik Cinčić, Tomislav Friščić, William Jones

Chemistry of Materials· Volume 20· Issue 21
Publisher page

Abstract

The structural equivalence of halogen-bonded iodine and bromine functionalities has been systematically explored as a general tool to construct isostructural cocrystal architectures with differing strengths of the constituent halogen bonds. By using acridine and phenazine as halogen bond acceptors, the structural equivalence of Br and I donors was tested for cocrystals based on discrete (0-dimensional) or infinite (1-dimensional chain) supramolecular topologies. In addition to being robust to changes in the topology of halogen-bonded assembly, this structural equivalence was also persistent in the presence of weak intermolecular hydrogen bonding of C−H···N type. The potential application of structurally equivalent I and Br donors in the design of molecular materials is illustrated by constructing pairs of solids that exhibit differing melting point, stability, and crystal morphology, although based on identical halogen-bonded architectures.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Metal-Organic Frameworks: Synthesis and Applications · Inorganic Fluorides and Related Compounds

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pfizer Institute for Pharmaceutical Materials Science, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB21EW, United Kingdom, and Laboratory of General and Inorganic Chemistry, Department of Chemistry, Faculty of Science, University of Zagreb, Zagreb HR-10000, Croatia

References (48)

Show source-provided references
1. Friščić T. · Faraday Discuss. · 2007 · 136 · 16710.1039/b616399h ↗
2. Zaworotko M. J. · Cryst. Growth Des. · 2007 · 7 · 410.1021/cg0680172 ↗
3. Ward M. D. · Chem. Commun. · 2005 · 583810.1039/b513077h ↗
4. Braga D. · Chem. Commun. · 2003 · 275110.1039/b306269b ↗
5. Aakeröy C. B. · J. Am. Chem. Soc. · 2002 · 124 · 1442510.1021/ja027845q ↗
6. Etter M. C. · J. Phys. Chem. · 1991 · 95 · 460110.1021/j100165a007 ↗
7. Bernstein J. · Nature Mater. · 2005 · 4 · 42710.1038/nmat1406 ↗
8. Braga D. · CrystEngComm · 2005 · 7 · 110.1039/b417413e ↗
9. Price S. L. · Adv. Drug Delivery Rev. · 2004 · 56 · 30110.1016/j.addr.2003.10.006 ↗
10. Bernstein J. · Angew. Chem., Int. Ed. · 1999 · 38 · 344110.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO;2-# ↗
11. Kálmán A. · Acta Cryst., Sect. B · 2005 · 61 · 53610.1107/S0108768105023189 ↗
12. Reddy C. M. · Chem.—Eur. J. · 2006 · 12 · 222210.1002/chem.200500983 ↗
13. Párkányi L. · Inorg. Chem. · 1994 · 33 · 18010.1021/ic00079a033 ↗
14. Friščić T. · Cryst. Growth Des. · 2008 · 8 · 160510.1021/cg700929e ↗
15. Bhogala B. R. · Cryst. Growth. Des. · 2005 · 5 · 168310.1021/cg058012p ↗
16. Bishop R. · Chem. Soc. Rev · 1996 · 25 · 31110.1039/cs9962500311 ↗
17. Loehlin J. H. · Chem. Mater. · 1994 · 6 · 121810.1021/cm00044a020 ↗
18. Etter M. C. · Chem. Mater. · 1989 · 1 · 1010.1021/cm00001a005 ↗
19. Vishweshwar P. · J. Pharm. Sci. · 2006 · 95 · 49910.1002/jps.20578 ↗
20. Jones W. · MRS Bull. · 2006 · 31 · 87510.1557/mrs2006.206 ↗
21. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
22. Sokolov A. N. · J. Am. Chem. Soc. · 2006 · 128 · 280610.1021/ja057939a ↗
23. Cheney M. L. · Cryst. Growth Des. · 2007 · 7 · 61610.1021/cg0701729 ↗
24. Friščić T. · Croat. Chem. Acta · 2006 · 79 · 327
25. Metrangolo P. · J. Polym. Sci., A: Polym. Chem. · 2007 · 45 · 110.1002/pola.21725 ↗
26. Sun A. · Science · 2006 · 312 · 103010.1126/science.1124621 ↗
27. Metrangolo P. · Acc. Chem. Res. · 2005 · 38 · 38610.1021/ar0400995 ↗
28. Metrangolo P. · CrystEngComm · 2006 · 8 · 94610.1039/b610454a ↗
29. Messina M. T. · Tetrahedron · 2001 · 57 · 854310.1016/S0040-4020(01)00794-3 ↗
30. Holmesland O. · Acta Chem. Scand. · 1966 · 20 · 260110.3891/acta.chem.scand.20-2601 ↗
31. Cinčić D. · Chem.—Eur. J. · 2008 · 14 · 74710.1002/chem.200701184 ↗
32. Theocharis C. R. · J. Am. Chem. Soc. · 1984 · 106 · 360610.1021/ja00324a032 ↗
33. Sacconi L. · J. Am. Chem. Soc. · 1965 · 87 · 310210.1021/ja01092a016 ↗
34. Jones W. · Chem. Commun. · 1983 · 144310.1039/c39830001443 ↗
35. Babu N. J. · Cryst. Growth Des. · 2006 · 6 · 175310.1021/cg060378u ↗
36. Dey A. · CrystEngComm · 2004 · 6 · 64210.1039/b416962j ↗
37. Bruce W. · New J. Chem. · 2008 · 32 · 47710.1039/B709107A ↗
38. Aakeröy C. B. · J. Am. Chem. Soc. · 2007 · 129 · 1377210.1021/ja073201c ↗
39. Aakeröy C. B. · Chem. Commun. · 2007 · 423610.1039/b707458a ↗
40. Nguyen K. L. · Nature Mater. · 2007 · 6 · 20610.1038/nmat1848 ↗
41. Braga D. · Angew. Chem., Int. Ed. · 2004 · 43 · 400210.1002/anie.200301721 ↗
42. Liu P.-H. · Org. Lett. · 2004 · 6 · 208110.1021/ol049734x ↗
43. Thalladi V. R. · CrystEngComm · 2000 · 17
44. Pedireddi V. R. · Chem. Commun. · 1996 · 99710.1039/CC9960000997 ↗
45. The analysis of the disorder using solid-state13C CP-MAS NMR was unsuccessful, due to the overlap of signals in (acr)2·(tfbb) and (acr)2·(tfib). Low-temperature (−60 °C) DSC thermograms are featureless for both cocrystals, indicating that the disorder is independent of temperature (see theSupporting Information).
46. De Santis A. · Chem.—Eur. J. · 2003 · 9 · 3910.1002/chem.200204655 ↗
47. Dabros M. · Angew. Chem., Int. Ed. · 2007 · 46 · 413210.1002/anie.200604830 ↗
48. Desiraju G. R. · Angew. Chem., Int. Ed. · 2007 · 46 · 834210.1002/anie.200700534 ↗